Severe chronic active Epstein-Barr virus infection associated with multiple necrotic lesions in the liver

Hepatology Research

Volumn 25, Issue 4, 2003, Pages 447-454

  Shibuya, Akitaka ^a   Tsuchihashi, Takeshi ^a   Watanabe, Masaaki ^a   Nakazawa, Takahide ^a   Takeuchi, Atsuko ^a   Sakurai, Keizou ^b   Mitomi, Hiroyuki ^a   Saigenji, Katsunori ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Coagulation necrosis; Cytotoxic T cell; EBV terminal repetitive sequence analysis; In situ hybridization; Interstitial pneumonitis; T cell lymphoma; Virus associated hemophagocytosis

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; CYCLOSPORIN A; GANCICLOVIR; MESSENGER RNA; PREDNISOLONE; T LYMPHOCYTE RECEPTOR; VIRUS RNA;

ADULT; ANTIBODY TITER; ARTICLE; BLOOD CLOTTING; CASE REPORT; CELL AGGREGATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYTOLYSIS; DEATH; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; EPSTEIN BARR VIRUS; ERYTHROPHAGOCYTOSIS; FEVER; GENE REARRANGEMENT; GENETIC ANALYSIS; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INFECTIOUS MONONUCLEOSIS; INTERSTITIAL PNEUMONIA; LIVER BIOPSY; LIVER CELL; LIVER DISEASE; LIVER NECROSIS; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MALE; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY FAILURE; T LYMPHOCYTE; VIRUS GENOME; WEIGHT REDUCTION;

EID: 0037398155     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(02)00311-X     Document Type: Article

References (24)

1. Cohen JI. Epstein-Barr virus infection. New Engl J Med 2000;343:481-92.
2. Jones JF, Ray CG, Minnich LL, Hicks MJ, Kibler R, Lucas DO. Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies. Ann Intern Med 1985;102:1-7.
3. Straus SE. The chronic mononucleosis syndrome. J Infect Dis 1988;157:405-12.
4. Okano M, Matsumoto S, Osato T, Sakiyama Y, Thiele GM, Purtilo DT. Severe chronic active Epstein-Barr virus infection syndrome. Clin Microbiol Rev 1991;4:129-35.
5. Kawa-Ha K, Ishihara S, Ninomiya T, et al. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest 1989;84:51-5.
6. Ishihara S, Okada S, Wakiguchi H, Kurashige T, Morishima T, Kawa-Ha K. Chronic active Epstein-Barr virus infection in children in Japan. Acta Paediatr 1995;84:1271-5.
7. Kawa-Ha K, Franco E, Doi S, et al. Successful treatment of chronic active Epstein-Barr virus infection with recombinant interleukin-2. Lancet 1987;1:154.
8. Sakai Y, Ohga S, Tonegawa Y, et al. Interferon-alpha therapy for chronic active Epstein-Barr virus infection: potential effect on the development of T-lymphoproliferative disease. J Pediatr Hematol Oncol 1998;20:342-6.
9. Deutsch J, Wolf H, Becker H, et al. Demonstration of Epstein-Barr virus DNA in a previously healthy boy with fulminant hepatic failure. Eur J Pediatr 1986;145:94-8.
10. Markin RS. Manifestations of Epstein-Barr virus-associated disorders in liver. Liver 1994;14:1-13.
11. Kikuchi K, Miyakawa H, Abe K, et al. Vanishing bile duct syndrome associated with chronic EBV infection. Digest Dis Sci 2000;45:160-5.
12. Wright CF, Reid AH, Tsai MM, et al. Detection of Epstein-Barr virus sequences in Hodgkin's disease by the polymerase chain reaction. Am J Pathol 1991;139:393-8.
13. Waldmann TA, Davis MM, Bongiovanni KF, Korsmeyer SJ. Rearrangements of genes for the antigen receptor on T cells as markers of lineage and clonality in human lymphoid neoplasms. New Engl J Med 1985;313:776-83.
14. Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986;47:883-9.
15. Kikuta H, Taguchi Y, Tomizawa K, et al. Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 1988;333:455-7.
16. Ohshima K, Shimazaki K, Sugihara M, et al. Clinicopathological findings of virus-associated hemophagocytic syndrome in bone marrow: association with Epstein-Barr virus and apoptosis. Pathol Int 1999;49:533-40.
17. Imai S, Sugiura M, Oikawa O, et al. Epstein-Barr virus (EBV)-carrying and -expressing T-cell lines established from severe chronic active EBV infection. Blood 1996;87:1446-57.
18. Tsui WM, Wong KF, Tse CC. Liver changes in reactive haemophagocytic syndrome. Liver 1992;12:363-7.
19. Watson HG, Goulden NJ, Manson LM, McDermid G, Gray JA, Parker AC. Virus-associated haemophagocytic syndrome: further evidence for a T-cell mediated disorder. Br J Haematol 1994;86:213-5.
20. Goodman ZD, Ishak KG, Sesterhenn IA. Herpes simplex hepatitis in apparently immunocompetent adults. Am J Clin Pathol 1986;85:694-9.
21. Jacques SM, Qureshi F. Herpes simplex virus hepatitis in pregnancy: a clinicopathologic study of three cases. Hum Pathol 1992;23:183-7.
22. Ruehm SG, Trojan A, Vogt P, Krause M, Krestin GP. CT appearances of hepatic involvement in systemic varicellazoster. Br J Radiol 1998;71:1317-9.
23. Oyama Y, Amano T, Hirakawa S, Hironaka K, Suzuki S, Ota Z. Haemophagocytic syndrome treated with cyclosporin A: a T cell disorder. Br J Haematol 1989;73:276-8.
24. Tsuda H, Shirono K. Successful treatment of virus-associated haemophagocytic syndrome in adults by cyclosporin A supported by granulocyte colony-stimulating factor. Br J Haematol 1996;93:572-5.